Mortality risk of antipsychotic augmentation for adult depression

Mortality risk of antipsychotic augmentation for adult depression

Show other versions (1)

Importance Randomized controlled trials have demonstrated increased all-cause mortality in elderly patients with dementia treated with newer antipsychotics. It is unknown whether this risk generalizes to non-elderly adults using newer antipsychotics as augmentation treatment for depression. Objectiv...

Full description

Bibliographic Details
Main Authors: Tobias Gerhard, T. Scott Stroup, Christoph U. Correll, Soko Setoguchi, Brian L. Strom, Cecilia Huang, Zhiqiang Tan, Stephen Crystal, Mark Olfson, James M. Wright
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526884/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526884/?tool=EBI

Similar Items